Chongqing Lummy Pharma Cancels YZY Biopharma Y400 Partnership, Secures Compensation
China’s Chongqing Lummy Pharmaceutical Co., Ltd (SHE: 300006) announced the termination of its strategic partnership...
Finance
Fermion Secures Series B Financing to Advance AI-Driven Drug Development
Guangzhou-based AI biotech Fermion has raised over RMB100 million ($14.8 million) in a Series B...
Biotree Raises $14.8M in Series A Financing to Expand Multi-Omics Platform
Shanghai-based multi-omics specialist Biotree has raised nearly RMB100 million ($14.8 million) in a Series A...
Ningbo HicRen Biotech Completes RMB100M Pre-Series C Financing for Orthopedic Robots
Ningbo HicRen Biotechnology Co., Ltd, a China-based robotics-driven minimally invasive orthopedics platform, announced the completion...
Shanghai Ark Bio Raises Series D Funding to Advance Pediatric and Respiratory Drug Pipeline
China-based Shanghai Ark Biopharmaceutical Co., Ltd has completed a Series D financing round, following its...
Bangbang Robot Raises USD 14.9M in Series B to Expand Mobility Tech
Shanghai-based Bangbang Robot Co., Ltd, a developer of assisted mobility technology, has raised nearly RMB...
Aden Secures USD 29.8M Series B+ Funding to Expand DRG/DIP Solutions
Beijing-based AI medical big data firm Aden, also known as Yading Data, has raised RMB...
Baifu Laser Raises RMB 100 Million in Series A Funding for Optoelectronic Equipment
China-based Nanjing Baifu Laser Technology Co., Ltd reportedly raised close to RMB 100 million (USD...
GeneRulor Medical Technology Raises Funds for Gene Editing Diagnostics
China-based gene editing specialist ZhuHai GeneRulor Medical Technology Co., Ltd. reportedly raised “tens of millions”...
Phil Rivers Tech Raises RMB 100 Million for Computational Medicine Push
Beijing-based Phil Rivers Tech, a computational medicine-empowered drug developer, reportedly raised close to RMB 100...
ClinChoice Raises USD 150M in Funding Led by Legend Capital for Expansion
Sino-US full-service Contract Research Organization (CRO) ClinChoice has reportedly raised USD 150 million in a...
Shenzhen TargetRx Raises Hundreds of Millions in Series B Financing for Drug Development
China-based Shenzhen TargetRx, Inc., a developer of small-molecule kinase inhibitors, reportedly raised “hundreds of millions”...
Zhejiang Medicine’s NovoCodex Subsidiary Receives RMB 402M Investment
China-based Zhejiang Medicine Co., Ltd (SHA: 600216) announced that investors will inject a financial dose...
Medicilon Biomedical Plans RMB 2.16B Private Placement for R&D Expansion
China-based Shanghai Medicilon Biomedical Co., Ltd has announced plans to raise RMB 2.16 billion (USD...
Beijing Tianshi Tongda Raises RMB 140M for Autoimmune Disease Therapies
China-based Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd has reportedly raised RMB 140 million (USD...
Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development
China-based Wuhan YZY Biopharma Co., Ltd has reportedly raised RMB 200 million (USD 29.8 million)...
Zhiyi Bio Raises RMB 100M in Series B++ Round for LBP Pipeline Development
China-based leading live biotherapeutics (LBP) company Guangzhou Zhiyi Biotechnology Co., Ltd has recently raised RMB...
Hengrui Medicine’s Generic Tacrolimus Wins NMPA Approval for Transplant Rejection Prevention
China-based Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) announced that it has received market approval...
Harbour BioMed’s Partner NK Celltech Raises RMB 100M in Series A Financing
China-based Harbour BioMed (HKG: 2142) announced that its strategic partner NK Celltech, a company focusing...
Corestar Biotech Secures Series A Funding for POCT R&D Expansion
Shenzhen-based point-of-care testing (POCT) specialist Corestar Biotechnology Co., Ltd has raised “tens of millions” of...